Taranabant CB1 Receptor Inverse Agonist for Management of Obe, No Country

Print

The percentage of men and women in England classified as obese has been increasing over time.
 
Next»

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development